Inflammatory Bowel Diseases

Cover image for Inflammatory Bowel Diseases

September 2004

Volume 10, Issue 5

Pages 491–703

  1. Original Articles

    1. Top of page
    2. Original Articles
    3. Clinical Review
    4. Basic Science on the Cutting Edge
    5. Guidelines
    6. Selected Summaries
    7. Letter to the Editors
    1. Could immunosuppressive drugs reduce recurrence rate after second resection for crohn disease? (pages 491–495)

      Arnaud Alves, Professor Yves Panis, Francisca Joly, Marc Pocard, Anne Lavergne-Slove, Yoram Bouhnik and Patrice Valleur

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00001

    2. Prospective evaluation of intestinal homing memory T cells in ulcerative colitis (pages 496–503)

      A. L. Hart, M. A. Kamm, S. C. Knight and Dr. A. J. Stagg

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00002

    3. Characterization and distribution of colonic dendritic cells in Crohn's disease (pages 504–512)

      Manuel A. Silva, Carolina B. López, Francine Riverin, Luc Oligny, José Menezes and Ernest G. Seidman

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00003

    4. A genome scan in 260 inflammatory bowel disease-affected relative pairs (pages 513–520)

      M. Michael Barmada, Steven R. Brant, Dan L. Nicolae, Jean-Paul Achkar, Carolien I. Panhuysen, Theodore M. Bayless, Judy H. Cho and Richard H. Duerr

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00004

    5. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease (pages 521–528)

      Ben R. K. Smith, Ian D. R. Arnott, Hazel E. Drummond, Elaine R. Nimmo and Jack Satsangi

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00005

    6. Intracellular polyamine levels of intestinal epithelial cells in inflammatory bowel disease (pages 529–535)

      T. S. Weiss, H. Herfarth, F. Obermeier, J. Ouart, D. Vogl, J. Schölmerich, K.-W. Jauch and G. Rogler

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00006

    7. Prevention of fibrosis in experimental colitis by captopril: The role of tgf-β1 (pages 536–545)

      Dov Wengrower, Giuliana Zannineli, Orit Pappo, Giovanni Latella, Mirna Sestieri, Amancay Villanova, Yoram Faitelson, Mark Pines and Eran Goldin

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00007

    8. Altered immune system glycosylation causes colitis in α1,2-fucosyltransferase transgenic mice (pages 546–556)

      Steven J. Brown, Ashley M. Miller, Peter J. Cowan, John Slavin, William R. Connell, Gregory T. Moore, Sally Bell, P. Ross Elliott, Paul V. Desmond and Anthony J. F. D'Apice

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00008

    9. Interleukin-10 knockout mouse: A model for studying bone metabolism during intestinal inflammation (pages 557–563)

      Stacey L. Cohen, Aideen M. Moore and Wendy E. Ward

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00009

    10. Catalposide, a compound isolated from Catalpa Ovata, attenuates induction of intestinal epithelial proinflammatory gene expression and reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice (pages 564–572)

      Sang-Wook Kim, Suck-Chei Choi, Eun-Young Choi, Kyoung-Suk Kim, Jae-Min Oh, Hyun-Ju Lee, Hyun-Mee Oh, Soonhag Kim, Berm-Seok Oh, Ku-Chan Kimm, Moo-Hyung Lee, Geom-Seog Seo, Tae-Hyeon Kim, Hyun-Cheol Oh, Won-Hong Woo, Youn-Seok Kim, Hyun-Ock Pae, Do-Sim Park, Hun-Taeg Chung and Dr. Chang-Duk Jun

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00010

    11. Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease (pages 573–577)

      Dr. Antonio Di Sabatino, Rachele Ciccocioppo, Elia Armellini, Raffaele Morera, Laura Ricevuti, Paolo Cazzola, Ilaria Fulle and Gino Roberto Corazza

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00011

    12. Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein (pages 578–583)

      Priv.-Doz. Dr. med. Karin Dilger, Matthias Schwab and Martin F. Fromm

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00012

    13. Annexin 1 Is Secreted in situ during ulcerative colitis in humans (pages 584–592)

      Dr. Nathalie Vergnolle, Philippe Pagès, Rosine Guimbaud, Stanislas Chaussade, Lionel Buéno, Jean Escourrou and Christine Coméra

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00013

    14. Intestinal interleukin-13 in pediatric inflammatory bowel disease patients (pages 593–598)

      Khadijeh Kadivar, Eduardo D. Ruchelli, Jonathan E. Markowitz, Magee L. DeFelice, Melissa L. Strogatz, Mitul M. Kanzaria, Krishna P. Reddy, Robert N. Baldassano, Daniel von Allmen and Kurt A. Brown

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00014

    15. Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease (pages 599–605)

      Jonathan E. Markowitz, Petar Mamula, J. Fernando delRosario, Robert N. Baldassano, James D. Lewis, Abbas F. Jawad, Keri Culton and Brian L. Strom

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00015

    16. Serum p53 antibodies in patients affected with ulcerative colitis (pages 606–611)

      Michele Cioffi, Gabriele Riegler, Maria Teresa Vietri, Paola Pilla, Luigi Caserta, Romano Carratù, Vincenzo Sica and Anna Maria Molinari

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00016

    17. Anxiety, functional health status, and coping ability in patients with ulcerative colitis who are undergoing colonoscopic surveillance (pages 612–617)

      Lena Oxelmark, Gun Nordström, Urban Sjöqvist and Robert Löfberg

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00017

    18. Impaired gastric acid and pancreatic enzyme secretion in patients with Crohn's disease may be a consequenece of a poor nutritional state (pages 618–625)

      T. A. Winter, S. J. D. O'Keefe, M. Callanan and T. Marks

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00018

    19. Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease (pages 626–631)

      Heleen Wiersma, Johanna C. Escher, Karin Dilger, Dietmar Trenk, Marc A. Benninga, Chris J. van Boxtel and Jan Taminiau

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00019

    20. Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis (pages 632–636)

      Dr. Robert G. Maunder and Gordon R. Greenberg

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00020

    21. Assessing the demand for psychological care in chronic diseases. Development and validation of a questionnaire based on the example of inflammatory bowel disease (pages 637–645)

      Wolfgang Miehsler, Martina Weichselberger, Anna Öfferlbauer-Ernst, Clemens Dejaco, Walter Reinisch, Harald Vogelsang, Klaus Machold, Tanja Stamm, Alfred Gangl and Gabriele Moser

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00021

    22. The epidemiology and phenotype of Crohn's disease in the Chinese population (pages 646–651)

      Dr. Rupert W.L. Leong, James Y. Lau and Joseph J.Y. Sung

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00022

    23. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease (pages 652–654)

      Sunanda Kane, Stanley M. Cohen and John Hart

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00023

    24. Fatal staphylococcal sepsis in Crohn's disease after infliximab (pages 655–656)

      Klaus R. Herrlinger, Annette Borutta, Gabriel Meinhardt, Eduard F. Stange and Klaus Fellermann

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00024

  2. Clinical Review

    1. Top of page
    2. Original Articles
    3. Clinical Review
    4. Basic Science on the Cutting Edge
    5. Guidelines
    6. Selected Summaries
    7. Letter to the Editors
    1. C-reactive protein as a marker for inflammatory bowel disease (pages 661–665)

      Séverine Vermeire, Gert Van Assche and Paul Rutgeerts

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00026

  3. Basic Science on the Cutting Edge

    1. Top of page
    2. Original Articles
    3. Clinical Review
    4. Basic Science on the Cutting Edge
    5. Guidelines
    6. Selected Summaries
    7. Letter to the Editors
    1. Regulatory T cells. Peace keepers in the gut (pages 666–676)

      Matthieu Allez and Lloyd Mayer

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00027

  4. Guidelines

    1. Top of page
    2. Original Articles
    3. Clinical Review
    4. Basic Science on the Cutting Edge
    5. Guidelines
    6. Selected Summaries
    7. Letter to the Editors
    1. Guidelines for immunizations in patients with inflammatory bowel disease (pages 677–692)

      Bruce E. Sands, Carmen Cuffari, Jeffry Katz, Subra Kugathasan, Jane Onken, Charles Vitek and Walter Orenstein

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00028

  5. Selected Summaries

    1. Top of page
    2. Original Articles
    3. Clinical Review
    4. Basic Science on the Cutting Edge
    5. Guidelines
    6. Selected Summaries
    7. Letter to the Editors
    1. “Is foe your friend?” (page 693)

      Kiron M. Das

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00029

    2. You say goodbye and I say aloe (pages 693–695)

      Adam S. Cheifetz

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00030

    3. Chromoendoscopy: An evolving standard in surveillance for ulcerative colitis (pages 695–696)

      R. Kiesslich and M. F. Neurath

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00031

    4. TO (I)B(D) OR NOD2 (I)B(D)–are paneth cells the answer? (pages 696–697)

      Houssam Mardini and Willem J.S. de Villiers

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00032

  6. Letter to the Editors

    1. Top of page
    2. Original Articles
    3. Clinical Review
    4. Basic Science on the Cutting Edge
    5. Guidelines
    6. Selected Summaries
    7. Letter to the Editors
    1. Crohn's disease, infliximab and idiopathic thrombocytopenic purpura (pages 698–700)

      Lisbeth A. Selby, David Hess, Harohalli Shashidar, Willem J.S. de Villiers and Lisbeth A. Selby

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00033

    2. Hypersensitivity reaction to azathioprine in a patient with ulcerative colitis. Infrequent manifestations (page 700)

      J. M. Calbo Mayo, M. Blasco Colmenarejo, P. J. Rivera Vaquerizo and M. Vicente Gutierrez

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00034

    3. Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection (pages 701–702)

      María del Valle García-Sánchez, Federico Gómez-Camacho, Antonio Poyato-González, Eva María Iglesias-Flores, Juan Francisco de Dios-Vega and Rocio Sancho-Zapatero

      Version of Record online: 14 DEC 2006 | DOI: 10.1097/00054725-200409000-00035

SEARCH

SEARCH BY CITATION